Zylox-Tonbridge Medical Technology Co., Ltd. 818.F Stock
Zylox-Tonbridge Medical Technology Co., Ltd. Price Chart
Zylox-Tonbridge Medical Technology Co., Ltd. 818.F Financial and Trading Overview
Contents
- Zylox-Tonbridge Medical Technology Co., Ltd. Price Chart
- Zylox-Tonbridge Medical Technology Co., Ltd. 818.F Financial and Trading Overview
- Valuation Measures
- Trading Information
- Financial Highlights
- Profile of Zylox-Tonbridge Medical Technology Co., Ltd.
- Q&A For Zylox-Tonbridge Medical Technology Co., Ltd. Stock
Zylox-Tonbridge Medical Technology Co., Ltd. stock price | 1.1 EUR |
Previous Close | 1.22 EUR |
Open | 1.26 EUR |
Bid | 1.22 EUR x N/A |
Ask | 1.33 EUR x N/A |
Day's Range | 1.26 - 1.26 EUR |
52 Week Range | 1.07 - 1.99 EUR |
Volume | 176 EUR |
Avg. Volume | 0 EUR |
Market Cap | 423.11M EUR |
Beta (5Y Monthly) | N/A |
PE Ratio (TTM) | N/A |
EPS (TTM) | -0.03 EUR |
Forward Dividend & Yield | N/A (N/A) |
Ex-Dividend Date | N/A |
1y Target Est | N/A |
818.F Valuation Measures
Enterprise Value | -1444447872 EUR |
Trailing P/E | N/A |
Forward P/E | N/A |
PEG Ratio (5 yr expected) | N/A |
Price/Sales (ttm) | 1.2664417 |
Price/Book (mrq) | 0.1342568 |
Enterprise Value/Revenue | -4.324 |
Enterprise Value/EBITDA | 7.099 |
Trading Information
Zylox-Tonbridge Medical Technology Co., Ltd. Stock Price History
Beta (5Y Monthly) | N/A |
52-Week Change | -6.15% |
S&P500 52-Week Change | 20.43% |
52 Week High | 1.99 EUR |
52 Week Low | 1.07 EUR |
50-Day Moving Average | 1.35 EUR |
200-Day Moving Average | 1.37 EUR |
818.F Share Statistics
Avg. Volume (3 month) | 0 EUR |
Avg. Daily Volume (10-Days) | 0 EUR |
Shares Outstanding | 324.62M |
Float | 129.84M |
Short Ratio | N/A |
% Held by Insiders | 35.98% |
% Held by Institutions | 31.22% |
Shares Short | N/A |
Short % of Float | N/A |
Short % of Shares Outstanding | N/A |
Dividends & Splits
Trailing Annual Dividend Rate | 0 |
Trailing Annual Dividend Yield | 0% |
5 Year Average Dividend Yield | N/A |
Payout Ratio | 0 |
Last Split Factor |
Financial Highlights
Fiscal Year
Fiscal Year Ends | December 31, 2022 |
Most Recent Quarter (mrq) | December 31, 2022 |
Next Fiscal Year End | December 31, 2023 |
Profitability
Profit Margin | -33.98% |
Operating Margin (ttm) | -66.90% |
Gross Margin | 75.62% |
EBITDA Margin | -60.90% |
Management Effectiveness
Return on Assets (ttm) | -4.29% |
Return on Equity (ttm) | -3.64% |
Income Statement
Revenue (ttm) | 334.09M EUR |
Revenue Per Share (ttm) | 1.01 EUR |
Quarterly Revenue Growth (yoy) | 70.39% |
Gross Profit (ttm) | N/A |
EBITDA | -203474000 EUR |
Net Income Avi to Common (ttm) | -113555000 EUR |
Diluted EPS (ttm) | -0.04 |
Quarterly Earnings Growth (yoy) | N/A |
Balance Sheet
Total Cash (mrq) | 1.86B EUR |
Total Cash Per Share (mrq) | 5.64 EUR |
Total Debt (mrq) | 14M EUR |
Total Debt/Equity (mrq) | 0.45 EUR |
Current Ratio (mrq) | 13.562 |
Book Value Per Share (mrq) | 9.385 |
Cash Flow Statement
Operating Cash Flow (ttm) | -91323000 EUR |
Levered Free Cash Flow (ttm) | -226740624 EUR |
Profile of Zylox-Tonbridge Medical Technology Co., Ltd.
Country | Germany |
State | N/A |
City | Hangzhou |
Address | Building 1 |
ZIP | N/A |
Phone | 86 571 8861 0082 |
Website | https://www.zyloxtb.com |
Industry | Medical Devices |
Sector(s) | Healthcare |
Full Time Employees | 715 |
Zylox-Tonbridge Medical Technology Co., Ltd., a medical device company, provides neuro- and peripheral-vascular interventional medical devices the People's Republic of China and internationally. The company develops neurovascular product portfolio that covers a suite of products for various categories, including ischemic stroke, hemorrhagic stroke, intracranial stenosis, carotid artery, and intracranial access devices. It also develops peripheral-vascular interventional product portfolio covering a spectrum of arterial and venous products comprising stents, balloons, catheters, and filters, as well as covers hemodialysis access, aortic intervention, peripheral embolization intervention, and radiological intervention products. In addition, the company provides technical consultation and services; as well as imports materials. The company was formerly known as Zhejiang Zylox Medical Device Co., Ltd. and changed its name to Zylox-Tonbridge Medical Technology Co., Ltd. in March 2021. Zylox-Tonbridge Medical Technology Co., Ltd. was incorporated in 2012 and is headquartered in Hangzhou, the People's Republic of China.
Q&A For Zylox-Tonbridge Medical Technology Co., Ltd. Stock
What is a current 818.F stock price?
Zylox-Tonbridge Medical Technology Co., Ltd. 818.F stock price today per share is 1.1 EUR.
How to purchase Zylox-Tonbridge Medical Technology Co., Ltd. stock?
You can buy 818.F shares on the Frankfurt exchange. Contact your financial advisor to select a broker.
What is the ticker symbol for Zylox-Tonbridge Medical Technology Co., Ltd.?
The stock symbol or ticker of Zylox-Tonbridge Medical Technology Co., Ltd. is 818.F.
Which industry does the Zylox-Tonbridge Medical Technology Co., Ltd. company belong to?
The Zylox-Tonbridge Medical Technology Co., Ltd. industry is Medical Devices.
How many shares does Zylox-Tonbridge Medical Technology Co., Ltd. have in circulation?
The max supply of Zylox-Tonbridge Medical Technology Co., Ltd. shares is 331.46M.
What is Zylox-Tonbridge Medical Technology Co., Ltd. Price to Earnings Ratio (PE Ratio)?
Zylox-Tonbridge Medical Technology Co., Ltd. PE Ratio is now.
What was Zylox-Tonbridge Medical Technology Co., Ltd. earnings per share over the trailing 12 months (TTM)?
Zylox-Tonbridge Medical Technology Co., Ltd. EPS is -0.03 EUR over the trailing 12 months.
Which sector does the Zylox-Tonbridge Medical Technology Co., Ltd. company belong to?
The Zylox-Tonbridge Medical Technology Co., Ltd. sector is Healthcare.